Jan H Beumer Selected Research

fludelone

11/2014

Quantitative method for the determination of iso-fludelone (KOS-1803) in human plasma by LC-MS/MS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan H Beumer Research Topics

Disease

70	Neoplasms (Cancer) 01/2022 - 10/2006
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2015 - 07/2006
7	Breast Neoplasms (Breast Cancer) 12/2019 - 08/2012
7	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 04/2011
6	Nausea 12/2019 - 01/2015
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 02/2013
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 04/2013
5	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 03/2012
4	Triple Negative Breast Neoplasms 01/2022 - 03/2012
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 03/2010
4	Lung Neoplasms (Lung Cancer) 12/2019 - 08/2013
4	Thrombocytopenia (Thrombopenia) 12/2019 - 01/2017
4	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 01/2013
3	Circulating Neoplastic Cells 01/2020 - 03/2012
3	Vomiting 12/2019 - 01/2015
3	Fatigue 10/2019 - 04/2013
3	Body Weight (Weight, Body) 01/2019 - 01/2017
3	Neoplasm Metastasis (Metastasis) 01/2019 - 03/2009
3	Lymphoma (Lymphomas) 12/2018 - 03/2012
3	Hematologic Neoplasms (Hematological Malignancy) 01/2017 - 08/2010
3	Carcinoma (Carcinomatosis) 10/2015 - 03/2009
3	Glioblastoma (Glioblastoma Multiforme) 07/2015 - 06/2009
3	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2014 - 07/2006
2	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 01/2019
2	Hypoxia (Hypoxemia) 12/2019 - 01/2015
2	Liver Diseases (Liver Disease) 11/2019 - 07/2013
2	Dehydration (Water Stress) 10/2019 - 08/2017
2	Mucositis 01/2019 - 01/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 05/2012
2	Squamous Cell Carcinoma of Head and Neck 01/2018 - 12/2016
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2018
2	Vulvar Neoplasms (Vulvar Cancer) 11/2017 - 01/2017
2	Fanconi Anemia (Fanconi's Anemia) 02/2017 - 10/2015
2	Adenocarcinoma 02/2016 - 04/2011
2	Sarcoma (Soft Tissue Sarcoma) 01/2015 - 05/2007

Drug/Important Bio-Agent (IBA)

22	Pharmaceutical PreparationsIBA 01/2022 - 05/2007
13	veliparibIBA 01/2022 - 03/2012
12	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 03/2012
11	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 07/2006
9	Histone Deacetylase InhibitorsIBA 01/2020 - 08/2010
7	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 01/2008
7	Cisplatin (Platino)FDA LinkGeneric 11/2017 - 01/2015
6	Vorinostat FDA Link 01/2020 - 10/2010
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2012
5	Tyrosine Kinase InhibitorsIBA 03/2022 - 05/2009
5	Alkylating AgentsIBA 01/2022 - 03/2012
5	Dasatinib (BMS 354825)FDA Link 11/2021 - 08/2013
5	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 06/2009
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2015
5	Phosphotransferases (Kinase)IBA 01/2018 - 10/2015
5	Cytochrome P-450 CYP3AIBA 11/2015 - 07/2006
4	PlatinumIBA 01/2022 - 01/2015
4	ElectrolytesIBA 10/2021 - 01/2014
4	nilotinib FDA Link 01/2018 - 07/2009
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 04/2011
3	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 01/2017
3	3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA 11/2020 - 01/2017
3	Gemcitabine FDA Link 01/2020 - 01/2017
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 12/2012
3	belinostatIBA 12/2019 - 07/2013
3	Carboplatin (JM8)FDA LinkGeneric 12/2019 - 01/2017
3	Cytotoxins (Cytolysins)IBA 12/2019 - 01/2017
3	src-Family KinasesIBA 01/2019 - 08/2013
3	Biological ProductsIBA 01/2018 - 01/2009
3	AndrogensIBA 01/2018 - 02/2013
3	NSC281612IBA 02/2015 - 01/2013
2	CopperIBA 01/2022 - 01/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 03/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2019
2	Disulfiram (Antabuse)FDA Link 01/2022 - 01/2019
2	ceralasertibIBA 01/2022 - 01/2018
2	neratinibIBA 01/2021 - 10/2019
2	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2020 - 05/2014
2	5-fluoro-2'-deoxycytidineIBA 01/2020 - 03/2015
2	MethyltransferasesIBA 01/2020 - 10/2006
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2019 - 11/2018
2	CreatinineIBA 01/2019 - 01/2019
2	NSC 724998IBA 12/2018 - 07/2016
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2018 - 01/2015
2	ixabepilone (BMS 247550)FDA Link 01/2018 - 01/2009
2	sulforaphaneIBA 01/2018 - 03/2009
2	enzalutamideIBA 01/2018 - 05/2017
2	LigandsIBA 01/2018 - 08/2014
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 11/2017 - 01/2017
2	muskIBA 10/2017 - 01/2015
2	AntiemeticsIBA 10/2017 - 01/2015
2	Poly Adenosine Diphosphate RiboseIBA 08/2017 - 03/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2017
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2016 - 11/2016
2	Histones (Histone)IBA 07/2016 - 08/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 07/2013
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2015 - 10/2013
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2015 - 08/2010
2	Ritonavir (Norvir)FDA Link 11/2014 - 10/2013
2	efavirenz (Sustiva)FDA Link 11/2014 - 10/2013

Therapy/Procedure

21	Therapeutics 01/2021 - 08/2010
16	Drug Therapy (Chemotherapy) 12/2019 - 12/2009
4	Castration 01/2018 - 08/2013
3	Radiotherapy 01/2018 - 02/2016
3	Chemoprevention 01/2018 - 08/2012